M.D. Anderson Cancer Center: Pancreatic Neoplasms trials

The registry lists 61 Pancreatic Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 7 are open to participants now and 16 have results posted.

Early Phase 1 1Phase 1 20Phase 2 24Phase 3 3Phase 4 1No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer PatientsNot yet recruitingNCT07591480
• Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing ScreeningRecruitingNCT07513116Not applicable
• Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyRecruitingNCT06651580
• Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialRecruitingNCT06593431Phase 3
• High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesRecruitingNCT05053555Not applicable
• iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D MutationRecruitingNCT03608631Phase 1/2
• Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerRecruitingNCT02361320Not applicable
• Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic SurgeryCompletedNCT03745794Phase 2Results posted
• Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic CancerCompletedNCT02907099Phase 2Results posted
• Olaparib in Treating Patients With Stage IV Pancreatic CancerCompletedNCT02677038Phase 2Results posted
• Gemcitabine Pharmacokinetics After Preoperative Chemoradiation TherapyTerminatedNCT01938716Not applicableResults posted
• Minocycline Study in Pancreatic Cancer PatientsCompletedNCT01693523Phase 2Results posted
• Comparison of a Novel 22-gauge Core Biopsy NeedleCompletedNCT01598194Not applicableResults posted
• Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasCompletedNCT01560949Phase 2Results posted
• Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or PancreasCompletedNCT01438476Phase 3Results posted
• Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer PatientsCompletedNCT00966277Phase 4Results posted
• Vorinostat Plus Radiation Therapy in Pancreatic CancerTerminatedNCT00831493Phase 1/2Results posted
• MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerCompletedNCT00769483Phase 1/2Results posted
• Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation TherapyTerminatedNCT00766636Phase 2Results posted
• Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerTerminatedNCT00640978Phase 2Results posted
• Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer PatientsCompletedNCT00338039Phase 2Results posted
• Trial of Curcumin in Advanced Pancreatic CancerCompletedNCT00094445Phase 2Results posted
• Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic CancerCompletedNCT00068575Phase 2Results posted
• TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic CancerSuspendedNCT07377526Phase 1/2
• A Trial of YL-13027 in Combination With Gemcitabine and Nab-paclitaxel in Patients With Refractory Metastatic Pancreatic CancerTerminatedNCT06199466Phase 1
• Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic CancerActive, not recruitingNCT05922930Phase 1/2
• Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic CancerActive, not recruitingNCT05836870Phase 3
• Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionActive, not recruitingNCT05677048Not applicable
• Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer PatientsWithdrawnNCT05634525Phase 1
• A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.Active, not recruitingNCT05497778Phase 1
• A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerActive, not recruitingNCT05394259Phase 1
• Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse EventsActive, not recruitingNCT05038254Not applicable
• Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic CancerActive, not recruitingNCT04940286Phase 2
• Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength StudyActive, not recruitingNCT04837118Not applicable
• NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic CancerActive, not recruitingNCT04484909Phase 1
• Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic CancerCompletedNCT04132505Phase 1
• Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic CancerWithdrawnNCT04058964Phase 2
• A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsCompletedNCT03784677Phase 1
• Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)Active, not recruitingNCT03460769
• Epacadostat and Pembrolizumab in Treating Participants With Advanced Pancreatic CancerWithdrawnNCT03432676Phase 2
• IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
• PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic CancerActive, not recruitingNCT03187951Not applicable
• 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in PatientsActive, not recruitingNCT03168737Phase 1
• Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic CancerStatus unknownNCT03058926
• Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerActive, not recruitingNCT02983578Phase 2
• Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by SurgeryCompletedNCT02930902Phase 1
• Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT02394535Phase 1
• Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic CancerCompletedNCT02295956Early Phase 1
• C-VISA BikDD: Liposome in Advanced Pancreatic CancerWithdrawnNCT00968604Phase 1
• Huachansu & Gemcitabine in Pancreatic CancerCompletedNCT00837239Phase 2
• Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic CancerCompletedNCT00805688
• Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic CancerCompletedNCT00614653Phase 1
• Pancreatic Cancer Genetic Epidemiology (PACGENE) StudyActive, not recruitingNCT00526578
• Chemoradiation-Induced Nausea and Emesis: Quality of LifeTerminatedNCT00394602
• Preop Chemoradiation Resectable PancreasCompletedNCT00336648Phase 2
• Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
• Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic CancerCompletedNCT00047710Phase 1
• Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of PancreasTerminatedNCT00038701Phase 2
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00003677Phase 2
• Interleukin-12 in Treating Patients With Cancer in the AbdomenCompletedNCT00003046Phase 1